The US Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) have announced a $500 ...

Danish allergy immunotherapy specialist ALK Abello (OMX: ALK B) has announced a four-year agreement with USA-based ARS ...

The global dermatological cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth ...

The pharmaceutical industry in Latin America is currently facing several challenges in terms of containment of chronic ...

Mergers and acquisitions (M&As) in the biopharmaceutical industry surged 101% in total deal value in first-quarter 2025 from ...

US biotech Jazz Pharmaceuticals (Nasdaq: JAZZ) is banking on continued growth from Epidiolex (cannabidiol), the first ...

Anglo-Swedish pharma major AstraZeneca has presented positive top-line results from the Phase III KALOS and LOGOS trials in ...

The head of the World Health Organization has issued a stark warning that sudden cuts to global health budgets, including by ...

The US Department of Health and Human Services has announced a sweeping change to the way new vaccines are evaluated, saying ...

Danish drugmaker Novo Nordisk (NOV: N) has secured a significant advantage in the high-stakes obesity drug market after ...

Cidara Therapeutics, a San Diego biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) ...

US biotech major Amgen (Nasdaq AMGN) late Thursday announced financial results for the first quarter of 2025, revealing that ...